Showing 1 to 12 of 52 results
Multiply Labs and Universal Robots Partner to Automate Cell Therapy Production
Multiply Labs, a San Francisco startup, partnered with Universal Robots to automate cell therapy production, aiming to reduce costs and increase manufacturing scale of these expensive and complex treatments.
Multiply Labs and Universal Robots Partner to Automate Cell Therapy Production
Multiply Labs, a San Francisco startup, partnered with Universal Robots to automate cell therapy production, aiming to reduce costs and increase manufacturing scale of these expensive and complex treatments.
Progress
56% Bias Score
AI and Edge Computing Revolutionize Healthcare: Guthrie Clinic Case Study
AI and edge computing are transforming healthcare by enabling real-time diagnostic insights, improving operational efficiency, and personalizing patient care, as demonstrated by the Guthrie Clinic's 70% reduction in patient falls and 85% increase in hospital transfer acceptance.
AI and Edge Computing Revolutionize Healthcare: Guthrie Clinic Case Study
AI and edge computing are transforming healthcare by enabling real-time diagnostic insights, improving operational efficiency, and personalizing patient care, as demonstrated by the Guthrie Clinic's 70% reduction in patient falls and 85% increase in hospital transfer acceptance.
Progress
52% Bias Score
Two-Week Breast Cancer Test Predicts Recurrence, Personalizes Treatment
A new test, after two weeks of hormone therapy, identifies breast cancer patients (6% of 213 studied) whose Luminal B tumors don't change subtype, indicating a need for intensive treatment; this impacts around 200,000 ER-positive, HER2-positive breast cancer cases globally yearly.
Two-Week Breast Cancer Test Predicts Recurrence, Personalizes Treatment
A new test, after two weeks of hormone therapy, identifies breast cancer patients (6% of 213 studied) whose Luminal B tumors don't change subtype, indicating a need for intensive treatment; this impacts around 200,000 ER-positive, HER2-positive breast cancer cases globally yearly.
Progress
36% Bias Score
Nasal Mucus: A Diagnostic and Therapeutic Goldmine
Nasal mucus, or boogers, protects against disease, and its color and microbiome indicate bodily responses; research uses analysis for early disease detection and personalized medicine.
Nasal Mucus: A Diagnostic and Therapeutic Goldmine
Nasal mucus, or boogers, protects against disease, and its color and microbiome indicate bodily responses; research uses analysis for early disease detection and personalized medicine.
Progress
48% Bias Score
AI-Driven Aneurysm Prediction Improves Cardiovascular Treatment
Kak Khee Yeung, a vascular surgery professor at Amsterdam UMC, delivered her inaugural lecture on July 4th, presenting research using AI to predict aneurysm rupture, considering factors like age, sex, lifestyle, and genetics, to personalize treatments and improve patient outcomes.
AI-Driven Aneurysm Prediction Improves Cardiovascular Treatment
Kak Khee Yeung, a vascular surgery professor at Amsterdam UMC, delivered her inaugural lecture on July 4th, presenting research using AI to predict aneurysm rupture, considering factors like age, sex, lifestyle, and genetics, to personalize treatments and improve patient outcomes.
Progress
28% Bias Score
AI: Revolutionizing Cancer Care Affordability and Outcomes
AI is revolutionizing cancer care, lowering costs and improving survival. Early detection tools, like those used at The Christ Hospital, increase early diagnoses. Personalized treatments, such as ArteraAI's Prostate Test, reduce unnecessary therapies. AI-powered surgery and infection monitoring (Tem...
AI: Revolutionizing Cancer Care Affordability and Outcomes
AI is revolutionizing cancer care, lowering costs and improving survival. Early detection tools, like those used at The Christ Hospital, increase early diagnoses. Personalized treatments, such as ArteraAI's Prostate Test, reduce unnecessary therapies. AI-powered surgery and infection monitoring (Tem...
Progress
40% Bias Score
NICE Recommends Personalized Treatment for Type 2 Diabetes in UK
NICE recommends personalized type 2 diabetes treatment in England, Wales, and Northern Ireland, prioritizing SGLT-2 inhibitors as first-line treatment for all 4.6 million diagnosed patients, potentially saving 22,000 lives and reducing NHS costs, but addressing unequal access is crucial.
NICE Recommends Personalized Treatment for Type 2 Diabetes in UK
NICE recommends personalized type 2 diabetes treatment in England, Wales, and Northern Ireland, prioritizing SGLT-2 inhibitors as first-line treatment for all 4.6 million diagnosed patients, potentially saving 22,000 lives and reducing NHS costs, but addressing unequal access is crucial.
Progress
48% Bias Score
Extensive Human Genome Sequencing Reveals Over 167,000 Structural Variants
Researchers sequenced 1,019 human genomes from diverse populations, discovering over 167,000 structural variants—double the previously known amount—improving understanding of rare diseases and cancer, and offering insights into human evolution and personalized medicine.
Extensive Human Genome Sequencing Reveals Over 167,000 Structural Variants
Researchers sequenced 1,019 human genomes from diverse populations, discovering over 167,000 structural variants—double the previously known amount—improving understanding of rare diseases and cancer, and offering insights into human evolution and personalized medicine.
Progress
44% Bias Score
Nasal Mucus: A Window into Health and Disease
Nasal mucus color and composition indicate health status: clear mucus suggests irritation, white a viral infection, yellow-green many dead leukocytes, and black a serious issue; research explores its microbiome's role in disease resistance and vaccine efficacy, with applications in personalized medi...
Nasal Mucus: A Window into Health and Disease
Nasal mucus color and composition indicate health status: clear mucus suggests irritation, white a viral infection, yellow-green many dead leukocytes, and black a serious issue; research explores its microbiome's role in disease resistance and vaccine efficacy, with applications in personalized medi...
Progress
4% Bias Score
Ultrahuman Launches Blood Vision: AI-Powered Blood Test and Smart Ring Health Tracking
Ultrahuman launched its Blood Vision health tracking service in the U.S., combining two blood tests (100+ and 60+ biomarkers) with data from its smart ring to provide AI-driven personalized insights on lifestyle and health, costing $499-$799 annually.
Ultrahuman Launches Blood Vision: AI-Powered Blood Test and Smart Ring Health Tracking
Ultrahuman launched its Blood Vision health tracking service in the U.S., combining two blood tests (100+ and 60+ biomarkers) with data from its smart ring to provide AI-driven personalized insights on lifestyle and health, costing $499-$799 annually.
Progress
44% Bias Score
Liquid Biopsy Speeds Cancer Diagnosis, Improves Patient Outcomes
A 41-year-old woman, Rebeca Proctor, diagnosed with stage 4 lung cancer in January, credits a rapid liquid biopsy which confirmed her cancer's genetic variant ten days sooner than a tissue biopsy, enabling immediate treatment with Brigatinib and significantly improving her quality of life; NHS Engla...
Liquid Biopsy Speeds Cancer Diagnosis, Improves Patient Outcomes
A 41-year-old woman, Rebeca Proctor, diagnosed with stage 4 lung cancer in January, credits a rapid liquid biopsy which confirmed her cancer's genetic variant ten days sooner than a tissue biopsy, enabling immediate treatment with Brigatinib and significantly improving her quality of life; NHS Engla...
Progress
44% Bias Score
Liquid Biopsy Shows Promise for Early Detection and Prevention of Breast Cancer Relapse
A new blood test, "liquid biopsy," detects breast cancer relapse earlier than traditional methods, allowing for preventive treatment with camizestrant, showing a 56% reduction in disease progression risk in a clinical trial involving 3000 patients.
Liquid Biopsy Shows Promise for Early Detection and Prevention of Breast Cancer Relapse
A new blood test, "liquid biopsy," detects breast cancer relapse earlier than traditional methods, allowing for preventive treatment with camizestrant, showing a 56% reduction in disease progression risk in a clinical trial involving 3000 patients.
Progress
48% Bias Score
Showing 1 to 12 of 52 results